Current Value of Holding

$79.3 Thousand

Shares

38 Thousand

% of Portfolio

0.00%

Average Buy Price

$15.9

Avg closing price
Price range

20 Paul Tudor Jones II Coherus Biosciences Trades

Paul Tudor Jones II acquired 38 Thousand Coherus Biosciences shares worth $79.3 Thousand. That's 0.00% of their equity portfolio (1336th largest holding). The first Coherus Biosciences trade was made in Q2 2016. Since then Paul Tudor Jones II bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $605 Thousand, resulting in a loss of 87%.

Avg closing price
Price range
Sold 31.6% shares (-17.6 Thousand shares) Q4 2023
Avg closing price $2.68
Price range $1.59 - $3.85
Increased shares by 30.1% (+12.8 Thousand shares) Q3 2023
Avg closing price $4.62
Price range $3.74 - $5.45
Increased shares by 1.6% (+683 shares) Q2 2023
Avg closing price $5.90
Price range $3.79 - $8.30
Increased shares by 14.1% (+5.18 Thousand shares) Q1 2023
Avg closing price $7.76
Price range $5.89 - $10.52
Increased shares by 56.0% (+13.2 Thousand shares) Q4 2022
Avg closing price $7.69
Price range $5.69 - $10.07
Sold 86.5% shares (-151 Thousand shares) Q3 2022
Avg closing price $10.12
Price range $7.17 - $13.87
Sold 7.2% shares (-13.6 Thousand shares) Q2 2022
Avg closing price $8.70
Price range $5.86 - $13.23
Sold 3.8% shares (-7.52 Thousand shares) Q1 2022
Avg closing price $12.72
Price range $10.92 - $16.41
New holding (+196 Thousand shares) Q4 2021
Avg closing price $17.49
Price range $15.81 - $18.99
Sold -16.5 Thousand shares Q1 2020
Avg closing price $18.48
Price range $11.67 - $22.53
New holding (+16.5 Thousand shares) Q4 2019
Avg closing price $18.44
Price range $16.33 - $21.37
Sold -30.8 Thousand shares Q2 2019
Avg closing price $17.37
Price range $13.10 - $22.10
New holding (+30.8 Thousand shares) Q1 2019
Avg closing price $13.34
Price range $8.38 - $15.50
Sold -19.5 Thousand shares Q4 2017
Avg closing price $10.71
Price range $8.35 - $14.40
Sold 32.0% shares (-9.18 Thousand shares) Q3 2017
Avg closing price $13.23
Price range $11.10 - $14.65
Increased shares by 23.5% (+5.46 Thousand shares) Q2 2017
Avg closing price $19.23
Price range $14.35 - $24.50
Increased shares by 61.3% (+8.83 Thousand shares) Q1 2017
Avg closing price $24.60
Price range $20.50 - $29.05
Increased shares by 34.9% (+3.73 Thousand shares) Q4 2016
Avg closing price $27.98
Price range $24.15 - $30.69
Sold 5.6% shares (-630 shares) Q3 2016
Avg closing price $27.28
Price range $16.43 - $31.57
New holding (+11.3 Thousand shares) Q2 2016
Avg closing price $18.77
Price range $14.13 - $23.85

News about Coherus Biosciences Inc and Paul Tudor Jones II

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!